Observational studyNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study.

Aurora Zanghì et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.